~ Buy the REZUROCK (belumosudil mesylate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR REZUROCK

All Clinical Trials for REZUROCK

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02841995 ↗	A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease	Active, not recruiting	Kadmon Corporation, LLC	Phase 2	2016-08-01	This study is being conducted to evaluate the safety, tolerability, and activity of belumosudil (formerly known as KD025) in adult subjects with chronic Graft versus Host Disease (cGVHD).
NCT03530995 ↗	Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Volunteers	Completed	Quotient Sciences	Phase 1	2018-04-28	This is a single-center, 2-part, non-randomized, open-label study of the drug-drug interactions of belumosudil (KD025) with itraconazole, rifampicin, rabeprazole, and omeprazole in healthy male subjects.
NCT03530995 ↗	Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Volunteers	Completed	Kadmon Corporation, LLC	Phase 1	2018-04-28	This is a single-center, 2-part, non-randomized, open-label study of the drug-drug interactions of belumosudil (KD025) with itraconazole, rifampicin, rabeprazole, and omeprazole in healthy male subjects.
NCT03640481 ↗	Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy	Recruiting	Kadmon Corporation, LLC	Phase 2	2018-10-15	This is a Phase 2, randomized, multicenter study to evaluate the efficacy and safety of KD025 in subjects with Chronic Graft Versus Host Disease (cGVHD) after at least 2 prior lines of systemic therapy
NCT05305989 ↗	Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213	Enrolling by invitation	Kadmon Corporation, LLC	Phase 2	2022-03-01	Extended Treatment and Follow-up of Subjects Treated with Belumosudil in Study KD025-208 or Study KD025-213

Clinical Trial Conditions for REZUROCK

Condition Name

Condition Name for REZUROCK
Intervention	Trials
Chronic Graft-versus-host-disease	2
Autoimmune Diseases	1
Chronic Graft Versus Host Disease	1
Drug Drug Interaction	1

Condition MeSH

Condition MeSH for REZUROCK
Intervention	Trials
Graft vs Host Disease	4
Autoimmune Diseases	1

Clinical Trial Locations for REZUROCK

Trials by Country

Trials by Country for REZUROCK
Location	Trials
United States	36
United Kingdom	1

Trials by US State

Trials by US State for REZUROCK
Location	Trials
Washington	3
California	3
Texas	3
Florida	2
Tennessee	2

Clinical Trial Progress for REZUROCK

Clinical Trial Phase

Clinical Trial Phase for REZUROCK
Clinical Trial Phase	Trials
Phase 2	4
Phase 1	1

Clinical Trial Status

Clinical Trial Status for REZUROCK
Clinical Trial Phase	Trials
Enrolling by invitation	1
Not yet recruiting	1
Active, not recruiting	1

Clinical Trial Sponsors for REZUROCK

Sponsor Name

Sponsor Name for REZUROCK
Sponsor	Trials
Kadmon Corporation, LLC	4
Quotient Sciences	1
Kadmon, a Sanofi Company	1

Sponsor Type

Sponsor Type for REZUROCK
Sponsor	Trials
Industry	6